Recall: D-0076-2027

Class II - Potentially Harmful

Class IIClassification
2026-10-06Initiated
OngoingStatus
Hikma Pharmaceuticals USA INC.Firm

Product

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Reason

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.